Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Return on Invested Capital: 2021-2023

Historic Return on Invested Capital for Pharming Group N.V (PHAR) over the last 1 years, with Mar 2023 value amounting to 0.01%.

  • Pharming Group N.V's Return on Invested Capital fell 5.00% to 0.01% in Q1 2023 from the same period last year, while for Mar 2023 it was 0.01%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.02% for FY2023, which is 10.00% down from last year.
  • Latest data reveals that Pharming Group N.V reported Return on Invested Capital of 0.01% as of Q1 2023, which was down 96.89% from 0.17% recorded in Q4 2022.
  • In the past 5 years, Pharming Group N.V's Return on Invested Capital registered a high of 0.43% during Q2 2021, and its lowest value of 0.01% during Q1 2023.
  • Over the past 3 years, Pharming Group N.V's median Return on Invested Capital value was 0.05% (recorded in 2022), while the average stood at 0.16%.
  • Examining YoY changes over the last 5 years, Pharming Group N.V's Return on Invested Capital showed a top increase of 14bps in 2022 and a maximum decrease of 39bps in 2022.
  • Pharming Group N.V's Return on Invested Capital (Quarterly) stood at 0.03% in 2021, then rose by 14bps to 0.17% in 2022, then declined by 5bps to 0.01% in 2023.
  • Its Return on Invested Capital stands at 0.01% for Q1 2023, versus 0.17% for Q4 2022 and 0.40% for Q3 2022.